Page 43
April 15-16, 2019 | Milan, Italy
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
alliedacademies.comYEARS
Joint Event on
&
PUBLIC HEALTH,
EPIDEMIOLOGY AND NUTRITION
2
nd
World Congress on
CELL AND GENE THERAPY
2
nd
International Conference on
Cell and Gene Therapy 2019 & Public Health Congress 2019
Archives of General Internal Medicine | ISSN: 2591-7951 | Volume 3
THE IMPACT OF Γ-IRRADIATION ON THE INDUCTION OF BYSTANDER KILLING BY
GENETICALLY ENGINEERED OVARIAN TUMOR CELLS: IMPLICATIONS FOR CLINICAL
USE AS CANCER VACCINES
Jehad Zweiri
University of Liverpool, United Kingdom
C
ellular based therapeutic approaches for cancer rely on careful consideration of finding the optimal cell to
execute the cellular goal of cancer treatment. Cell lines and primary cell cultures have been used in some
studies to compare the
in vitro
and
in vivo
efficacy of autologous vs allogeneic tumour cell vaccines. This study
examines the effect of γ-irradiation on a range of tumor cell lines in conjunction with suicide gene therapy of
cancer. To determine the efficacy of this modality, a series of
in vitro
and
in vivo
experiments were conducted
using genetically modified and unmodified tumor cell lines. Following co-culture of HSV-TK modified tumor
cells and unmodified tumor cells both
in vitro
and
in vivo
we observed that the PA-STK ovarian tumor cells were
sensitive to γ-irradiation, completely abolishing their ability to induce bystander killing of unmodified tumor
cells. In contrast, TK-modified human and mouse mesothelioma cells were found to retain their
in vitro
and
in
vivo
bystander killing effect after γ-irradiation. Characterisation of tumor cell death showed that PA-STK cells
underwent pyknosis (necrosis) after γ-irradiation. These results suggest that PA-STK cells are not suitable for
clinical application of suicide gene therapy of cancer, as lethal γ-irradiation (100Gy) interferes with their by-
stander killing activity. However, the human mesothelioma cell line CRL-5830-TK retained its bystander killing
potential after exposure to similarly lethal γ-irradiation (100Gy). CRL-5830 may therefore be a suitable vehicle
for HSV-TK suicide gene therapy. This study highlights the diversity among tumor cell lines and the careful con-
siderations needed to find the optimal tumor cell line for this type of whole cell tumour vaccination.
Arch Gen Intern Med 2019, Volume 3 | DOI: 10.4066/2591-7951-C2-027